Literature DB >> 9395061

Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis.

A S Johnson1, A R Gorringe, A J Fox, R Borrow, A Robinson.   

Abstract

Subcapsular antigens, including transferrin binding proteins, are being considered as potential vaccines against serogroup B meningococci. This study examined the human isotype antibody responses in cases of meningococcal disease to meningococcal TbpA (transferrin binding protein A) and TbpB (transferrin binding protein B) from two strains (SD and B16B6) expressing high and low molecular mass TbpB respectively. TbpA isolated from both strains were recognised more frequently and higher durable ELISA absorbance values were detected than those detected against TbpB from either strain. These antibody responses to Tbps were independent of the infecting meningococcal strain type. The antibody response to the four proteins was highly variable between individuals and differed significantly against all four antigens. The variability of immune responses to each Tbp from the two strains suggests that a successful vaccine would need to include TbpA and TbpB from a number of strains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395061     DOI: 10.1111/j.1574-695X.1997.tb01085.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

1.  Immunogenicity of gonococcal transferrin binding proteins during natural infections.

Authors:  Gregory A Price; Marcia M Hobbs; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes.

Authors:  A K Lehmann; A R Gorringe; K M Reddin; K West; I Smith; A Halstensen
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

3.  The gonococcal Fur-regulated tbpA and tbpB genes are expressed during natural mucosal gonococcal infection.

Authors:  Sarika Agarwal; Carol A King; Ellen K Klein; David E Soper; Peter A Rice; Lee M Wetzler; Caroline A Genco
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine.

Authors:  B Rokbi; G Renauld-Mongenie; M Mignon; B Danve; D Poncet; C Chabanel; D A Caugant; M J Quentin-Millet
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

5.  Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

Authors:  D West; K Reddin; M Matheson; R Heath; S Funnell; M Hudson; A Robinson; A Gorringe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 6.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Patterns of structural and sequence variation within isotype lineages of the Neisseria meningitidis transferrin receptor system.

Authors:  Paul Adamiak; Charles Calmettes; Trevor F Moraes; Anthony B Schryvers
Journal:  Microbiologyopen       Date:  2015-03-19       Impact factor: 3.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.